›› 2013, Vol. 28 ›› Issue (11): 1051-1054.DOI: 10.3969/j.issn.1673-8640.2013.11.023
• Orginal Article • Previous Articles Next Articles
Received:2013-04-09
Online:2013-11-30
Published:2013-12-20
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2013.11.023
| [1] Dispenzieri A,Kyle R,Merlini G,et al. International myeloma working group guidelines for serum-free light chain analysis in multiple myeloma and related dis-orders[J]. Leukemia,2009,23(2): 215-224. [2] Brouwer J, Otting-van de Ruit M,Busking-van der Lely H. Estimation of free light chains of immunoglobulins by enzyme immunoassay[J]. Clin Chim Acta,1985,150(3): 267-274. [3] 陈文彬,潘祥林.诊断学[M].第7版.北京:人民卫生出版社,2007:12. [4] Hutchison CA,Harding S,Hewins P,et al. Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease[J]. Clin J Am Soc Nephrol,2008,3(6): 1684-1690. [5] Katzmann JA,Abraham RS,Dispenzieri A,et al. Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice[J]. Clin Chem,2005,51(5):878-881. [6] 康 懿,刘 华,王 蕾,等. 血清κ/λ轻链比值及蛋白电泳在诊断多发性骨髓瘤中的临床应用[J]. 检验医学,2011,26(10): 675-678. [7] Boege F. Measuring Bence Jones proteins with antibodies against bound immunoglobulin light-chains:how reliable are the results[J]. Eur J Clin Chem Clin Biochem,1993,31(6):403-405. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
